CARETRUST REIT INC (CTRE) Fundamental Analysis & Valuation

NYSE:CTRE • US14174T1079

Current stock price

39.46 USD
+0.7 (+1.81%)
Last:

This CTRE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

9

1. CTRE Profitability Analysis

1.1 Basic Checks

  • CTRE had positive earnings in the past year.
  • CTRE had a positive operating cash flow in the past year.
  • CTRE had positive earnings in 4 of the past 5 years.
  • Each year in the past 5 years CTRE had a positive operating cash flow.
CTRE Yearly Net Income VS EBIT VS OCF VS FCFCTRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M -400M -600M -800M

1.2 Ratios

  • The Return On Assets of CTRE (6.21%) is better than 97.52% of its industry peers.
  • The Return On Equity of CTRE (7.93%) is better than 80.17% of its industry peers.
  • CTRE's Return On Invested Capital of 5.13% is amongst the best of the industry. CTRE outperforms 92.56% of its industry peers.
  • CTRE had an Average Return On Invested Capital over the past 3 years of 5.00%. This is in line with the industry average of 3.11%.
  • The last Return On Invested Capital (5.13%) for CTRE is above the 3 year average (5.00%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.21%
ROE 7.93%
ROIC 5.13%
ROA(3y)4.13%
ROA(5y)3.25%
ROE(3y)5.32%
ROE(5y)4.57%
ROIC(3y)5%
ROIC(5y)5.23%
CTRE Yearly ROA, ROE, ROICCTRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 4 6 8

1.3 Margins

  • CTRE's Profit Margin of 67.13% is amongst the best of the industry. CTRE outperforms 97.52% of its industry peers.
  • In the last couple of years the Profit Margin of CTRE has grown nicely.
  • With an excellent Operating Margin value of 67.48%, CTRE belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • CTRE's Operating Margin has improved in the last couple of years.
  • CTRE has a Gross Margin of 99.83%. This is amongst the best in the industry. CTRE outperforms 100.00% of its industry peers.
  • CTRE's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 67.48%
PM (TTM) 67.13%
GM 99.83%
OM growth 3Y4.4%
OM growth 5Y2.84%
PM growth 3YN/A
PM growth 5Y8.23%
GM growth 3Y0.81%
GM growth 5YN/A
CTRE Yearly Profit, Operating, Gross MarginsCTRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

4

2. CTRE Health Analysis

2.1 Basic Checks

  • CTRE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, CTRE has more shares outstanding
  • Compared to 5 years ago, CTRE has more shares outstanding
  • The debt/assets ratio for CTRE is higher compared to a year ago.
CTRE Yearly Shares OutstandingCTRE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
CTRE Yearly Total Debt VS Total AssetsCTRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.2 Solvency

  • An Altman-Z score of 4.83 indicates that CTRE is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 4.83, CTRE belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • CTRE has a Debt/Equity ratio of 0.22. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.22, CTRE belongs to the top of the industry, outperforming 96.69% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Altman-Z 4.83
ROIC/WACC0.59
WACC8.67%
CTRE Yearly LT Debt VS Equity VS FCFCTRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B

2.3 Liquidity

  • CTRE has a Current Ratio of 1.07. This is a normal value and indicates that CTRE is financially healthy and should not expect problems in meeting its short term obligations.
  • CTRE has a Current ratio of 1.07. This is comparable to the rest of the industry: CTRE outperforms 57.85% of its industry peers.
  • CTRE has a Quick Ratio of 1.07. This is a normal value and indicates that CTRE is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.07, CTRE perfoms like the industry average, outperforming 58.68% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.07
Quick Ratio 1.07
CTRE Yearly Current Assets VS Current LiabilitesCTRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

7

3. CTRE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 89.02% over the past year.
  • CTRE shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 12.77% yearly.
  • The Revenue has grown by 60.79% in the past year. This is a very strong growth!
  • The Revenue has been growing by 21.72% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)89.02%
EPS 3Y38.77%
EPS 5Y12.77%
EPS Q2Q%56.25%
Revenue 1Y (TTM)60.79%
Revenue growth 3Y34.43%
Revenue growth 5Y21.72%
Sales Q2Q%116.82%

3.2 Future

  • CTRE is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.13% yearly.
  • Based on estimates for the next years, CTRE will show a quite strong growth in Revenue. The Revenue will grow by 17.38% on average per year.
EPS Next Y-2.7%
EPS Next 2Y0.47%
EPS Next 3Y3.13%
EPS Next 5YN/A
Revenue Next Year31.91%
Revenue Next 2Y22.3%
Revenue Next 3Y17.38%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CTRE Yearly Revenue VS EstimatesCTRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M
CTRE Yearly EPS VS EstimatesCTRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5

3

4. CTRE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 25.46, which means the current valuation is very expensive for CTRE.
  • Compared to the rest of the industry, the Price/Earnings ratio of CTRE indicates a somewhat cheap valuation: CTRE is cheaper than 75.21% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of CTRE to the average of the S&P500 Index (27.15), we can say CTRE is valued inline with the index average.
  • The Price/Forward Earnings ratio is 26.16, which means the current valuation is very expensive for CTRE.
  • Based on the Price/Forward Earnings ratio, CTRE is valued cheaply inside the industry as 85.95% of the companies are valued more expensively.
  • CTRE's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.12.
Industry RankSector Rank
PE 25.46
Fwd PE 26.16
CTRE Price Earnings VS Forward Price EarningsCTRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • 84.30% of the companies in the same industry are cheaper than CTRE, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 22.55
CTRE Per share dataCTRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • The excellent profitability rating of CTRE may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.99
EPS Next 2Y0.47%
EPS Next 3Y3.13%

6

5. CTRE Dividend Analysis

5.1 Amount

  • CTRE has a Yearly Dividend Yield of 4.11%, which is a nice return.
  • CTRE's Dividend Yield is comparable with the industry average which is at 7.43.
  • CTRE's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 4.11%

5.2 History

  • The dividend of CTRE has a limited annual growth rate of 5.26%.
  • CTRE has paid a dividend for at least 10 years, which is a reliable track record.
  • CTRE has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)5.26%
Div Incr Years10
Div Non Decr Years10
CTRE Yearly Dividends per shareCTRE Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • CTRE pays out 81.10% of its income as dividend. This is not a sustainable payout ratio.
  • CTRE's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP81.1%
EPS Next 2Y0.47%
EPS Next 3Y3.13%
CTRE Yearly Income VS Free CF VS DividendCTRE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M -400M -600M -800M
CTRE Dividend Payout.CTRE Dividend Payout, showing the Payout Ratio.CTRE Dividend Payout.PayoutRetained Earnings

CTRE Fundamentals: All Metrics, Ratios and Statistics

CARETRUST REIT INC

NYSE:CTRE (4/28/2026, 3:09:55 PM)

39.46

+0.7 (+1.81%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-12
Earnings (Next)05-07
Inst Owners106.09%
Inst Owner Change0.32%
Ins Owners0.34%
Ins Owner Change-0.23%
Market Cap8.81B
Revenue(TTM)476.39M
Net Income(TTM)319.80M
Analysts83.53
Price Target44.37 (12.44%)
Short Float %7.22%
Short Ratio5.45
Dividend
Industry RankSector Rank
Dividend Yield 4.11%
Yearly Dividend1.27
Dividend Growth(5Y)5.26%
DP81.1%
Div Incr Years10
Div Non Decr Years10
Ex-Date03-31
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)16.23%
Min EPS beat(2)-4.24%
Max EPS beat(2)36.71%
EPS beat(4)2
Avg EPS beat(4)6.54%
Min EPS beat(4)-6.76%
Max EPS beat(4)36.71%
EPS beat(8)3
Avg EPS beat(8)-11.03%
EPS beat(12)3
Avg EPS beat(12)-24.14%
EPS beat(16)4
Avg EPS beat(16)-27.24%
Revenue beat(2)2
Avg Revenue beat(2)24.53%
Min Revenue beat(2)19.52%
Max Revenue beat(2)29.53%
Revenue beat(4)3
Avg Revenue beat(4)9.21%
Min Revenue beat(4)-15.93%
Max Revenue beat(4)29.53%
Revenue beat(8)5
Avg Revenue beat(8)7.46%
Revenue beat(12)7
Avg Revenue beat(12)5.5%
Revenue beat(16)9
Avg Revenue beat(16)3.94%
PT rev (1m)1.16%
PT rev (3m)6.88%
EPS NQ rev (1m)-1.25%
EPS NQ rev (3m)-9.35%
EPS NY rev (1m)-3.09%
EPS NY rev (3m)-6.91%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)-1.58%
Revenue NY rev (1m)0.47%
Revenue NY rev (3m)2.79%
Valuation
Industry RankSector Rank
PE 25.46
Fwd PE 26.16
P/S 18.49
P/FCF N/A
P/OCF 22.36
P/B 2.18
P/tB 2.18
EV/EBITDA 22.55
EPS(TTM)1.55
EY3.93%
EPS(NY)1.51
Fwd EY3.82%
FCF(TTM)-4.28
FCFYN/A
OCF(TTM)1.77
OCFY4.47%
SpS2.13
BVpS18.08
TBVpS18.08
PEG (NY)N/A
PEG (5Y)1.99
Graham Number25.1078 (-36.37%)
Profitability
Industry RankSector Rank
ROA 6.21%
ROE 7.93%
ROCE 6.49%
ROIC 5.13%
ROICexc 5.34%
ROICexgc 5.34%
OM 67.48%
PM (TTM) 67.13%
GM 99.83%
FCFM N/A
ROA(3y)4.13%
ROA(5y)3.25%
ROE(3y)5.32%
ROE(5y)4.57%
ROIC(3y)5%
ROIC(5y)5.23%
ROICexc(3y)5.47%
ROICexc(5y)5.54%
ROICexgc(3y)5.47%
ROICexgc(5y)5.54%
ROCE(3y)6.33%
ROCE(5y)6.62%
ROICexgc growth 3Y-3.3%
ROICexgc growth 5Y-1.42%
ROICexc growth 3Y-3.3%
ROICexc growth 5Y-1.42%
OM growth 3Y4.4%
OM growth 5Y2.84%
PM growth 3YN/A
PM growth 5Y8.23%
GM growth 3Y0.81%
GM growth 5YN/A
F-Score6
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Debt/EBITDA 2.16
Cap/Depr 1449.83%
Cap/Sales 283.17%
Interest Coverage 8.07
Cash Conversion 95.06%
Profit Quality N/A
Current Ratio 1.07
Quick Ratio 1.07
Altman-Z 4.83
F-Score6
WACC8.67%
ROIC/WACC0.59
Cap/Depr(3y)1122.58%
Cap/Depr(5y)756.87%
Cap/Sales(3y)224.11%
Cap/Sales(5y)158.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)89.02%
EPS 3Y38.77%
EPS 5Y12.77%
EPS Q2Q%56.25%
EPS Next Y-2.7%
EPS Next 2Y0.47%
EPS Next 3Y3.13%
EPS Next 5YN/A
Revenue 1Y (TTM)60.79%
Revenue growth 3Y34.43%
Revenue growth 5Y21.72%
Sales Q2Q%116.82%
Revenue Next Year31.91%
Revenue Next 2Y22.3%
Revenue Next 3Y17.38%
Revenue Next 5YN/A
EBIT growth 1Y67.35%
EBIT growth 3Y40.34%
EBIT growth 5Y25.18%
EBIT Next Year54.67%
EBIT Next 3Y25.22%
EBIT Next 5Y21.69%
FCF growth 1Y-65.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y61.32%
OCF growth 3Y39.74%
OCF growth 5Y22.02%

CARETRUST REIT INC / CTRE Fundamental Analysis FAQ

What is the fundamental rating for CTRE stock?

ChartMill assigns a fundamental rating of 6 / 10 to CTRE.


What is the valuation status of CARETRUST REIT INC (CTRE) stock?

ChartMill assigns a valuation rating of 3 / 10 to CARETRUST REIT INC (CTRE). This can be considered as Overvalued.


How profitable is CARETRUST REIT INC (CTRE) stock?

CARETRUST REIT INC (CTRE) has a profitability rating of 9 / 10.


What are the PE and PB ratios of CARETRUST REIT INC (CTRE) stock?

The Price/Earnings (PE) ratio for CARETRUST REIT INC (CTRE) is 25.46 and the Price/Book (PB) ratio is 2.18.


Is the dividend of CARETRUST REIT INC sustainable?

The dividend rating of CARETRUST REIT INC (CTRE) is 6 / 10 and the dividend payout ratio is 81.1%.